Anglo-US biotech Ottimo Pharma has completed a big early-stage biotech financing, raising $140 million for its PD-1 and VEGF ...

Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured "over" $140 million in ...

Mersana Therapeutics is utilizing antibody-drug conjugates to target new immune checkpoints and revolutionize cancer ...

Drs Kathy Miller and Francisco J. Esteva discuss testing and therapeutic options for the new classification of HER2-ultra-low breast cancer.

See how Checkpoint Therapeutics, Inc.'s FDA-approved Unloxcyt drug for cSCC is set to disrupt the market with innovative ...

As global markets experience fluctuations with major indexes like the Nasdaq Composite reaching new highs, small-cap stocks face challenges as evidenced by the Russell 2000's recent underperformance.

Wellington Management Group LLP lifted its stake in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 16.2% during the third quarter, according to its most recent disclosure with the Securities ...

We recently compiled a list of the 10 Chinese Penny Stocks to Buy According to Analysts. In this article, we are going to ...

USA News Group News Commentary ? The American Cancer Society recently released its Advances in Oncology ? 2024 Research Highlights report that highlighted how their scientists continued to set the ...